Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis

This publication has 24 references indexed in Scilit:

• Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
  New England Journal of Medicine, 1999
• Activation of B‐lymphocytes during pollen season. Effect of immunotherapy
  Clinical and Experimental Allergy, 1998
• Therapeutic potential of anti-IgE antibodies
  Current Opinion in Immunology, 1997
• Interpretation of rhinoconjunctivitis quality of life questionnaire data
  Journal of Allergy and Clinical Immunology, 1996
• The rationale for use of topical corticosteroids in allergic rhinitis
  Clinical and Experimental Allergy, 1996
• Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)
  European Respiratory Journal, 1996
• Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.
  The Journal of Experimental Medicine, 1996
• The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure
  Journal of Allergy and Clinical Immunology, 1991
• Allergy and allergy‐like symptoms in 1,050 medical students
  Allergy, 1991
• Epidemiology of the Allergic Diseases: Are They Really on the Increase?
  International Archives of Allergy and Immunology, 1989